TXG

10x Genomics Inc-class A

+$659.0M

Net Activity

Institutions Holding

328

Popularity Rank

#1815

Avg Weight

0.17%

Total Value

$2.7B

Ownership Trend

328 institutions currently hold TXG, with 163 net buyers and 144 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

144

Net Buying Institutions

163

Key Holders

View all 328 holding institutions

Quarterly Activity

Recent Activity

+$1.4B

Total Buy Value

$978.9M

Total Sell Value

New buy47
Trim102
Add116
Sold out42

163

Net Buyers

144

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$184K

Total Est. Value

6K shares

Planned Shares

Last Filed 2026-06-16
FilerFiling DateEst. Value
SULIMAN SHEHNAAZ2026-06-16$184K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding 10X GENOMICS INC-CLASS A (TXG)?
Major stakeholders currently include FMR LLC ($376.6M), ARK Investment Management LLC ($248.8M), BlackRock, Inc. ($214.0M). Based on the latest 13F filings, there are a total of 328 tracked investment funds and institutions maintaining positions in TXG.
What is the overall institutional sentiment toward TXG recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $659.0M, driven by 163 managers accumulating shares while 144 reduced their exposure.
Which institutions have been selling or reducing their TXG positions?
In the latest period, 102 funds trimmed their holdings, and 42 managers completely exited their positions. The aggregate reported sell value was $978.9M.
Are there any notable investors adding TXG to their portfolios?
Yes, buying activity remains notable. 47 institutions opened new positions in {ticker}, and 116 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.4B.

Related Stocks